P

Paratek Pharmaceuticals Inc
F:N4CN

Watchlist Manager
Paratek Pharmaceuticals Inc
F:N4CN
Watchlist
Price: 2.024 EUR Market Closed
Market Cap: 115.9m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of N4CN.

The Intrinsic Value is calculated as the average of DCF and Relative values:

N4CN Intrinsic Value
Not Available
Base Case Scenario
Compare N4CN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about N4CN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Paratek Pharmaceuticals Inc

Current Assets 105.2m
Cash & Short-Term Investments 42.7m
Receivables 42.5m
Other Current Assets 20m
Non-Current Assets 40.6m
PP&E 2.2m
Intangibles 829k
Other Non-Current Assets 37.5m
Current Liabilities 202.6m
Accounts Payable 3m
Accrued Liabilities 35.2m
Short-Term Debt 164m
Other Current Liabilities 423k
Non-Current Liabilities 144.5m
Long-Term Debt 94.3m
Other Non-Current Liabilities 50.3m
Efficiency

Free Cash Flow Analysis
Paratek Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Paratek Pharmaceuticals Inc

Revenue
177m USD
Cost of Revenue
-25.3m USD
Gross Profit
151.7m USD
Operating Expenses
-196.2m USD
Operating Income
-44.5m USD
Other Expenses
-18.2m USD
Net Income
-62.7m USD
Fundamental Scores

N4CN Profitability Score
Profitability Due Diligence

Paratek Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
ROIC is Increasing
Exceptional ROE
Exceptional Gross Margin
hidden
Profitability
Score

Paratek Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

N4CN Solvency Score
Solvency Due Diligence

Paratek Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Paratek Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

N4CN Price Targets Summary
Paratek Pharmaceuticals Inc

There are no price targets for N4CN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for N4CN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y